Horizon Discovery has entered into a large-scale licensing agreement with a Japanese medical university for the use of 250 of Horizon’s X-MAN genetically defined, isogenic cell lines from its in vitro disease models.   Horizon’s X-MAN cell lines model the disease-causing mutations found in cancer and other diseases. Horizon creates these cell lines using its precision genome-editing GENESIS platform to engineer specific disease-related mutations. These models help researchers understand complex ...